Assessing cardiovascular risk in hepatitis C: An unmet need
about
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients.Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection.Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
P2860
Assessing cardiovascular risk in hepatitis C: An unmet need
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Assessing cardiovascular risk in hepatitis C: An unmet need
@ast
Assessing cardiovascular risk in hepatitis C: An unmet need
@en
Assessing cardiovascular risk in hepatitis C: An unmet need
@nl
type
label
Assessing cardiovascular risk in hepatitis C: An unmet need
@ast
Assessing cardiovascular risk in hepatitis C: An unmet need
@en
Assessing cardiovascular risk in hepatitis C: An unmet need
@nl
prefLabel
Assessing cardiovascular risk in hepatitis C: An unmet need
@ast
Assessing cardiovascular risk in hepatitis C: An unmet need
@en
Assessing cardiovascular risk in hepatitis C: An unmet need
@nl
P2860
P356
P1476
Assessing cardiovascular risk in hepatitis C: An unmet need
@en
P2093
Javier Ampuero
Manuel Romero-Gómez
P2860
P304
P356
10.4254/WJH.V7.I19.2214
P407
P577
2015-09-01T00:00:00Z